Yeah, Shkreli probably sold it short -- here's mor
Post# of 1460
Quote:
While in his 20s, he drew negative attention for urging the Food and Drug Administration not to approve drugs made by companies whose stock he was selling short.
He was among a group of investors ordered by a New York judge to pay $2.3 million to Lehman Brothers to cover a losing bet on the markets in 2007.
Two former employees sued him for not paying their wages, while another former employee accused Mr. Shkreli of taking over his personal email and Facebook accounts and harassing his family through social media.
The board of his first pharmaceutical company accused him of using the company as his personal piggy bank to pay back angry investors in his hedge fund.
This link goes to NY Times, so if you are not a subscriber, it will use up one of your 10 free articles a month:
http://www.nytimes.com/2015/09/23/business/bi....html?_r=0